Titration Troubleshooting and Safety

Professional Explanation

Persistent Obstructive Events

Verify events are real (not artifact), patient is asleep, leak is not compromising delivery, interface is properly fitted. If verified and ordered/protocol limit reached, notify clinician. Mode change may be appropriate.

Persistent or Emergent Central Events

When central apneas appear or worsen as pressure increases, consider TECSA. Central events on CPAP or spontaneous bilevel generally do not respond to increased pressure and may worsen. Assess pattern, verify events are central, consider whether mode with backup is indicated under order. Notify clinician.

Treatment-Emergent Central Sleep Apnea

TECSA is the emergence of central apneas during PAP therapy after obstructive events are controlled. May resolve with continued use in some patients; may require mode change in others. Identify the pattern and escalate.

High Leak

Large unintentional leak reduces delivered pressure, impairs event detection, causes arousals. Check mask seal, assess for mouth leak, verify circuit connections. Correct leak before concluding pressure is insufficient. If unresolved, titration results may be unreliable.

Signal Artifact and Wake Breathing

Not every irregularity is a respiratory event. Wake breathing is irregular. Sleep-wake transitions produce irregular patterns not treated with pressure changes. Distinguish artifact from real events.

Patient Distress and Intolerance

Signs include repeated arousals, anxiety, claustrophobia, aerophagia, excessive dryness. Address comfort, reassure, consider pressure or mask adjustments. If patient cannot tolerate therapy, titration cannot proceed — escalate.

When to Stop or Pause

Per protocol: significant distress, severe/persistent desaturation, cardiac rhythm concerns, patient request, unresolvable equipment malfunction, ordered limits reached without control.

When to Escalate

Notify clinician when: central events emerge or worsen, ordered maximum reached without control, significant desaturation occurs, patient cannot tolerate therapy, mode change beyond order is needed, equipment failure compromises study, any safety concern arises.

ELI-10

Troubleshooting is detective work. When something is not working, investigate — do not keep doing the same thing. Check simple fixes first (mask position). Recognize when the problem needs a mode change. When unsure or the patient is not safe, escalate. Do not guess.

ELI Example

A good driver pulls over to investigate a strange noise rather than ignoring it. Titration troubleshooting is the same — investigate, fix simple issues, and call for help when needed. You do not keep driving with smoke coming from the engine.

Do Not Confuse

• Troubleshooting (identifying and correcting the problem) and ignoring the problem

• Escalating (notifying clinician per protocol) and independently changing the treatment plan

• Temporary pause (patient needs a break) and treatment failure (mode or settings not working)

High-Yield Memory Anchors

• If not working, investigate — do not just repeat the same action

• Central events on CPAP → do not increase → consider mode/escalation

• Artifact and wake breathing are not treated with pressure changes

• Unresolved leak = unreliable titration

• Patient distress = pause and address comfort

Chapter Recap

Troubleshooting requires systematic assessment and correction of addressable problems, with escalation when issues exceed authorized scope. Safety always takes priority. Central events, high leak, patient intolerance, and unresolved obstruction each require specific approaches.

CHAPTER 11

Common Mistakes

• Continuing to increase pressure when events are central

• Treating wake irregularity as respiratory events

• Ignoring leak and assuming pressure is the problem

• Failing to address comfort, then wondering why titration cannot proceed

• Not escalating when at limits or when safety is a concern

Safety and Scope

Work within order, protocol, scope. Notify clinician when titration is not proceeding as expected. Never continue unsafe therapy or exceed authorized parameters.